KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $10,000 | -56.5% | 3,012 | -49.8% | 0.00% | – |
| Q2 2018 | $23,000 | +53.3% | 6,000 | +64.2% | 0.00% | – |
| Q1 2018 | $15,000 | +25.0% | 3,654 | +39.8% | 0.00% | – |
| Q4 2017 | $12,000 | -80.6% | 2,613 | -70.1% | 0.00% | – |
| Q3 2017 | $62,000 | -81.7% | 8,725 | -84.1% | 0.00% | – |
| Q1 2017 | $338,000 | +3.0% | 54,822 | -2.2% | 0.00% | – |
| Q4 2016 | $328,000 | – | 56,031 | +65052.3% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 86 | -17.3% | 0.00% | – |
| Q2 2016 | $1,000 | -92.3% | 104 | -96.2% | 0.00% | – |
| Q1 2016 | $13,000 | -83.3% | 2,704 | -82.4% | 0.00% | – |
| Q4 2015 | $78,000 | -79.5% | 15,357 | -85.8% | 0.00% | – |
| Q3 2015 | $381,000 | +97.4% | 108,180 | +459.5% | 0.00% | – |
| Q2 2015 | $193,000 | +36.9% | 19,334 | +74.8% | 0.00% | – |
| Q1 2015 | $141,000 | -68.2% | 11,063 | -64.8% | 0.00% | – |
| Q4 2014 | $444,000 | +26.1% | 31,415 | +22.9% | 0.00% | – |
| Q3 2014 | $352,000 | +190.9% | 25,569 | +225.4% | 0.00% | – |
| Q2 2014 | $121,000 | +8.0% | 7,857 | +19.6% | 0.00% | – |
| Q1 2014 | $112,000 | -80.1% | 6,572 | -84.9% | 0.00% | – |
| Q4 2013 | $562,000 | +5520.0% | 43,422 | +4144.6% | 0.00% | – |
| Q3 2013 | $10,000 | – | 1,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |